|
David F. Hale, Director - Mr. Hale has served on our board of directors since April 1997. Mr. Hale has served as President and Chief Executive Officer of CancerVax Corporation since October 2000 and as a director of CancerVax since December 2000. Prior to joining CancerVax, he was President and Chief Executive Officer of Women First HealthCare, Inc. from January 1998 to May 2000. Mr. Hale served as President, Chief Executive Officer and Chairman of Gensia from May 1987 to November 1997. Prior to joining Gensia, Mr. Hale was President and Chief Executive Officer of Hybritech Inc. Mr. Hale serves on the board of directors of several privately-held biotechnology companies, including Xcel Pharmaceuticals, Inc., Santarus, Inc., LMA North America, Inc., Somaxon Pharmaceuticals, Inc., SkinMedica, Inc. and Verus, Inc. Mr. Hale also serves as Chairman of BIOCOM/San Diego and on the board of the California Healthcare Institute and the BIO Emerging Growth Companies Section Governing Body. Mr. Hale received a B.A. in biology and chemistry from Jacksonville State University.
| 